Holen Sie sich die Stockscreener-App
74.90
0.24%
-0.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$75.08
Offen:
$75.25
24-Stunden-Volumen:
2.65M
Relative Volume:
0.92
Marktkapitalisierung:
$35.18B
Einnahmen:
$5.56B
Nettoeinkommen (Verlust:
$247.25M
KGV:
141.56
EPS:
0.5291
Netto-Cashflow:
$1.24B
1W Leistung:
-3.14%
1M Leistung:
-6.39%
6M Leistung:
+19.34%
1J Leistung:
+28.54%
1-Tages-Spanne:
$74.84
$76.54
1-Wochen-Bereich:
$73.82
$77.35
52-Wochen-Spanne:
$56.97
$81.89
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Vergleichen Sie VTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
74.90 | 35.27B | 5.56B | 247.25M | 1.24B | 0.5291 |
|
WELL
Welltower Inc
|
186.08 | 127.87B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
OHI
Omega Healthcare Investors Inc
|
44.27 | 13.20B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
16.71 | 11.84B | 2.80B | 279.29M | 1.20B | 0.40 |
|
AHR
American Healthcare Reit Inc
|
47.28 | 8.43B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Will Ventas Inc. stock benefit from green energy trendsQuarterly Profit Summary & Weekly Sector Rotation Insights - ulpravda.ru
Ventas (NYSE:VTR) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating - MarketBeat
Ventas, Inc. $VTR Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Will Ventas Inc. (VEN) stock beat Nasdaq index returnsAnalyst Downgrade & AI Based Buy/Sell Signal Reports - ulpravda.ru
Is Ventas (VTR) Offering Value After Recent Share Price Pullback And DCF Upside? - simplywall.st
Mizuho Securities Adjusts Ventas Price Target to $87 From $75, Maintains Outperform Rating - MarketScreener
Ventas (VTR) Gets a Hold from UBS - The Globe and Mail
Goldman Sachs initiates Ventas stock with Buy rating, $94 price target - Investing.com India
KLP Kapitalforvaltning AS Has $13.45 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Can Ventas Inc. stock sustain free cash flow growth2025 Major Catalysts & AI Powered Trade Plan Recommendations - ulpravda.ru
How Ventas Inc. stock benefits from global expansionJuly 2025 Setups & Advanced Swing Trade Entry Alerts - ulpravda.ru
Ventas Highlights New Material Agreement and Debt Obligations - The Globe and Mail
Will Ventas Inc. stock beat revenue estimatesWeekly Trading Summary & Long-Term Growth Stock Strategies - ulpravda.ru
20 People to Know in Accounting: Jakson Deyer - The Business Journals
Ventas Currently Down Seven Consecutive Days, On Pace for Longest Losing Streak Since August 2023 -- Data Talk - 富途牛牛
Is Ventas Inc. stock a safe haven assetEarnings Summary Report & Fast Moving Stock Trade Plans - ulpravda.ru
Aug Summary: Is Ventas Inc. stock a safe haven assetMarket Growth Report & Free Community Consensus Stock Picks - ulpravda.ru
Don't Be Fooled By These REITs In 2026 - Seeking Alpha
UBS Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $77 - 富途牛牛
Ventas Stock Tries To Rebuild Momentum: Healthcare REIT Tests Investor Patience - AD HOC NEWS
Ventas Incunit amends credit agreementSEC filing - MarketScreener
Ventas Signs Credit Agreement Amendment With Bank of America and Lenders - TradingView — Track All Markets
Ventas (NYSE: VTR) boosts term loan capacity and adds $550M delayed draw - Stock Titan
The Truth About Ventas Inc (VTR): Boring Name, Wild Upside? Read This Before You Buy - AD HOC NEWS
Ventas (NYSE:VTR) CFO Sells $2,312,092.50 in Stock - MarketBeat
Insider Selling: Ventas (NYSE:VTR) CEO Sells $797,477.72 in Stock - MarketBeat
Ventas (VTR) director adds to holdings via deferred fee stock grant - Stock Titan
Ventas (VTR) director reports 662.744 stock units via fee deferral plan - Stock Titan
Ventas (VTR) director reports 420.277 deferred stock units and 91,967.22 shares owned - Stock Titan
Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $93 - 富途牛牛
Key reasons to add Ventas stock to your portfolio right now - MSN
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Wall Street Is Suddenly Obsessed With Ventas Inc. – Is This Sleepy REIT Your Next Power Play? - AD HOC NEWS
Ventas Inc. Stock Is Quietly Waking Up: Smart Money REIT Play or Total Snooze? - AD HOC NEWS
What's in the Offing for Ventas Stock This Earnings Season? - MSN
Trading Systems Reacting to (VTR) Volatility - Stock Traders Daily
Tangible book value per share of Ventas, Inc. – GETTEX:VEN - TradingView — Track All Markets
VTR (NYSE: VTR) insider files notice to sell 29,930 common shares - Stock Titan
Ventas (NYSE: VTR) insider Debra Cafaro plans 10,322-share Rule 144 sale - Stock Titan
Vanderbilt University Sells 15,485 Shares of Ventas, Inc. $VTR - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 52,000 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Acquired by Cwm LLC - MarketBeat
Ventas Stock: Quiet Year-End Rally Puts This Healthcare REIT Back On Income Investors’ Radar - AD HOC NEWS
Ventas Sets Comprehensive Goals for DEI - Nareit
Ventas Stock: Defensive Yield Play Or Dormant Growth Story? - AD HOC NEWS
Pacer Advisors Inc. Lowers Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc.: - marketscreener.com
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Investors Buy Large Volume of Call Options on Ventas (NYSE:VTR) - MarketBeat
Top performing healthcare REITs year to date - Seeking Alpha
Aug Volume: Is Ventas Inc stock prepared for digital transitionJuly 2025 Gainers & Reliable Volume Spike Alerts - moha.gov.vn
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):